Ocadlikova, D. (2026) “CO45 | Targeting IDO1 and ATP catabolism overcomes the tolerogenic effects of cytarabine on acute myeloid leukemia immune microenvironment: <a href="https://haematologica.org/search/search?query=D.+Ocadlikova">D. Ocadlikova</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=P.+Portararo">P. Portararo</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=E.+Adinolfi">E. Adinolfi</a><sup>3</sup>, <a href="https://haematologica.org/search/search?query=E.+De+Marchi">E. De Marchi</a><sup>3</sup>, <a href="https://haematologica.org/search/search?query=A.+Pegoraro">A. Pegoraro</a><sup>3</sup>, <a href="https://haematologica.org/search/search?query=E.+Orioli">E. Orioli</a><sup>3</sup>, <a href="https://haematologica.org/search/search?query=S.+Sangaletti">S. Sangaletti</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=A.+Curti">A. Curti</a><sup>1</sup> | <i><sup>1</sup>IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ‘Seràgnoli’; <sup>2</sup>Fondazione IRCCS, Istituto Nazionale dei Tumori; <sup>3</sup>Department of Medical Sciences, University of Ferrara, Italy.</i&gt;”, Haematologica. Pavia, Italy, 111(s1). doi: 10.3324/haematol.2026.s1.49.